Survive VT: A Step Closer to "Smashing" Ischemic Ventricular Tachycardia?
- PMID: 35422241
- DOI: 10.1016/j.jacc.2022.01.051
Survive VT: A Step Closer to "Smashing" Ischemic Ventricular Tachycardia?
Keywords: antiarrhythmia drugs; catheter ablation; substrate modification; ventricular tachycardia.
Conflict of interest statement
Funding Support and Author Disclosures Dr Saleem has received consulting fees from Medtronic and Boston Scientific; and has received speaking fees from Janssen. Dr Costanzo serves on the Steering Committee of the GUIDE-HF Trial sponsored by Abbott.
Comment on
-
Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia.J Am Coll Cardiol. 2022 Apr 19;79(15):1441-1453. doi: 10.1016/j.jacc.2022.01.050. J Am Coll Cardiol. 2022. PMID: 35422240 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources